JUN 03, 2017 4:40 PM PDT

"Deprescribing" Cholesterol Drugs for Patients Nearing End of Life

WRITTEN BY: Kara Marker

Scientists from Oregon State University are testing the waters for people with “life-limiting” illnesses such as cancer and heart disease who might feel comfortable going off of medications they take to manage cholesterol, a process researchers are now calling “deprescribing.”

Credit: Medical News Today

Oregon State scientists believe that deprescribing statins originally prescribed to regulate cholesterol levels could improve health outcomes for people nearing the end of their life, a time where enhancing quality of life is more important than ever.

Statins are able to reduce levels of cholesterol by blocking the liver enzymes that produce it. This reduction prevents plaque buildup on the lining of blood vessels that contributes to atherosclerosis, stroke, or heart attack. However, these drugs are also infamous for side effects like muscle pain, digestive problems, and “mental fuzziness.”

"There's a lot of concern that patients will feel like doctors are giving up on them if they start to discontinue some of their medications, that there's something comforting about continuing to take their medications, and this gives us some indication of what patients feel about the risks and benefits of deprescribing,” study researcher Jon Furuno explained. The research team provided a questionnaire for study participants to express their concerns.

There were nearly 300 people overall enrolled in the recent Oregon State study, with an average age of 72 and life expectancy of less than one year. A large majority were cancer patients, and some had heart disease or other life-limiting disease. The study aimed to analyze the safety and effects of deprescribing stains by taking some participants off of the drug and some continue the drug. Despite Furuno’s concerns, less than five percent of the participants were actually concerned about being taking off of their statins, in fact, they seemed optimistic about what taking less drugs could do for their quality of life.

"Hopefully this will help inform prescribers who might be tentative to address this topic with their patients," Furuno said about the study. "As a patient's prognosis changes and we think they have a relatively short lifespan left, it really requires risk/benefit re-examination of everything we're doing for them, medications and everything else. There may still be benefits, but have the benefits changed or has the risk/benefit ratio changed?”

Furuno’s study was published in the Journal of Palliative Medicine.

Sources: Oregon State University, Mayo Clinic

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 08, 2021
Genetics & Genomics
A Slowdown in Cells' Protein Construction Drives Huntington's
MAR 08, 2021
A Slowdown in Cells' Protein Construction Drives Huntington's
Huntington's disease begins with symptoms like movement and balance problems, weakness, and behavioral disturbances, and ...
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
MAR 23, 2021
Microbiology
Pregnant Moms Easily Pass On COVID-19 Antibodies Through Placenta
MAR 23, 2021
Pregnant Moms Easily Pass On COVID-19 Antibodies Through Placenta
Recent work has shown that SARS-CoV-2 antibodies that are carried by a pregnant woman can cross the placenta and reach t ...
MAR 26, 2021
Cell & Molecular Biology
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
MAR 26, 2021
New 'Bio-ink' Gets 3D-Printed Organs Closer to Reality
For the many people waiting for transplants, 3D-printed organs can't come soon enough. Researchers have been making stri ...
MAR 29, 2021
Cardiology
Learning More About How Stress Breaks the Heart
MAR 29, 2021
Learning More About How Stress Breaks the Heart
Scientists are learning more about what causes a real phenomenon known as broken heart syndrome, or stress-related cardi ...
MAR 30, 2021
Drug Discovery & Development
Common Alzheimer's Drugs Reduce Mortality Rate and Cognitive Decline
MAR 30, 2021
Common Alzheimer's Drugs Reduce Mortality Rate and Cognitive Decline
Researchers from the Karolinska Institute and Umea University in Sweden have found that a commonly recommended group of ...
Loading Comments...